Updated:19 Jun 2013 03:45:00 PM(IST)
Sensex19245.70
22.42 0.12%
Nifty5822.25
8.65 0.15%
USD/INR57.87
-0.34 -0.59%
ISIN: INE899B01015 | Industry: Pharmaceuticals - Indian - Formulations | BSE Code: 530207 | Comments
| Price Information | |
| Open | 3.97 |
| High | 3.97 |
| Low | 3.97 |
| Previous Close | 3.97 |
| Shares Traded | 100 |
| 52 Wk High Price | 11.27 |
| 52 Wk High Date | 14-01-2013 |
| 52 Wk Low Price | 3.97 |
| 52 Wk Low Date | 12-06-2013 |
| Face Value | 10.00 |
| Fundamentals | |
| Market Capital (Rs.cr) | 1.19 |
| EPS (Rs.)(TTM) | 1.20 |
| P/E Ratio(TTM) | 3.30 |
| Book Value (Rs.) | 15.10 |
| Price to Book Value | 0.26 |
| Equity (Rs.cr.) | 3.00 |
| Traded Value (Rs.lac) | - |
| Related Companies | ||
| Stock Name | Price | |
| AMBASARABH | 2.45 | |
| AMRUTANJAN | 128.25 | |
| BLISSGVS | 31.65 | |
| GERMANREMEDIES | 473.20 | - |
| MAKERSLABORATORIES | 18.75 | |
| RHONEPOULENCI | 363.30 | - |
| TND | 53.00 | - |
| PHAREASTLABS | 2.80 | - |
| MJ | 5.25 | - |
| TWILITAKA | 3.60 | |
| Key Financials | Latest Qrtr. | Trailing Yr. | Full Yr. |
| Year End | Mar, 2013 | Mar, 2013 | Mar, 2013 |
| Sales (Rs.cr) | 6.75 | 24.55 | 24.55 |
| Net Profit (Rs.cr) | 0.02 | 0.35 | 0.35 |
| Net Profit Var (%) | -60.00 | - | - |
| EPS (Rs) | - | 1.20 | 1.20 |
| P/E Ratio | - | 3.30 | 3.30 |
| Operating Profit Margin | - | 2.60 | - |
| CPS (Rs.) | - | - | 1.20 |
| P/C Ratio | - | - | 3.30 |
| Div% | - | - | - |
Gross Deliverables
| Date | Del. Shares | Trd. Qty. | Del.(%) | Del. Value | Turnover |
| 28-05-2013 | 300 | 315 | 95.24 | 1446 | 1.52 |
| 11-05-2013 | 200 | 200 | 100.00 | 1124 | 1.12 |
| 10-05-2013 | 50 | 50 | 100.00 | 268 | 0.27 |
| 03-05-2013 | 500 | 500 | 100.00 | 2825 | 2.83 |
| 23-04-2013 | 201 | 301 | 66.78 | 1136 | 1.76 |
Note:
- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, %
change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date &
not adjusted with corporate action
Comment(s) posted on Brawn Biotech Ltd